Das DK,Maulik N.Resveratrol in cardioprotection:a therapeutic promise of alternative medicine[J].Mol Interv,2006,6(1):36-47.
[2]
Sliwinska J,Dudka J,Korga A,et al.Tirapazaminedoxorubicin interaction referring to heart oxidative stress and Ca2+balance protein levels[J].Oxid Med Cell Longev,2012,2012:890826.
Ruan BF,Lu XQ,Song J,et al.Derivatives of resveratrol:potential agents in prevention and treatment of cardiovascular disease[J].Curr Med Chem,2012,19(24):4 175-4 183.
[5]
Saeki K,Obi I,Ogiku N,et al.Doxorubicin directly binds to the cardiac-type ryanodine receptor[J].Life Sci,2002,70(20):2 377-2 389.
[6]
Deng J,Liu W,Wang Y,et al.Polydatin modulates Ca(2+)handling,excitation-contraction coupling andβ-adrenergic signaling in rat ventricular myocytes[J].J Mol Cell Cardiol,2012,53(5):646-656.
[7]
Hanna AD,Lam A,Tham S,et al.Adverse effects of doxorubicin and its metabolic product on cardiac RyR2and SERCA2A[J].Mol Pharmacol,2014,86(4):438-449.
[8]
Wu JM,Hsieh TC,Wang Z.Cardioprotection by resveratrol:a review of effects/targets in cultured cells and animal tissues[J].Am J Cardiovasc Dis,2011,1(1):38-47.
[9]
Xu Q,Si LY.Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action[J].Nutr Res,2012,32(9):648-658.
[10]
Dong Q,Wu Z,Li X,et al.Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca2+cycling proteins[J].J Transl Med,2014,12(1):323.
[11]
Jiang X,Liu W,Deng J,et al.Polydatin protects cardiac function against burn injury by inhibiting sarcoplasmic reticulum Ca2+leak by reducing oxidative modification of ryanodine receptors[J].Free Radic Biol Med,2013,60:292-299.
